Bixiye
QP56-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda dhaqangalka Barnaamijka: Jul 14, 2021
Natiijooyinka Raadinta
Soo bandhiga 1691 - 1700 ee natiijooyinka 4296
Bixiye
QP54-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective September 1, 2021
Taariikhda dhaqangalka Barnaamijka: Jul 14, 2021
Bixiye
P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P18-21 New Reimbursement Policy for Minnesota Health Care Programs Modifier 90: Reference (Outside) Laboratory and Pass-Through Billing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P11R1-21 UPDATE: Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P19-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P16-21 Genetic/Molecular Lab Test Coding Reimbursement Policy for MHCP
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
2021 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P17-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021